Detalhe da pesquisa
1.
High Tolerability, Favorable Safety, and Subjects' Preference for a Single 200 mg/2 mL Tildrakizumab Injection: A Phase I, Open-Label, Randomized Crossover Trial in Healthy Volunteers.
Dermatol Ther (Heidelb)
; 12(9): 2135-2144, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35984626
2.
Typical investigational medicinal products follow relatively uniform regulations in 10 European Clinical Research Infrastructures Network (ECRIN) countries.
Trials
; 13: 27, 2012 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22452964
3.
Compassionate use of interventions: results of a European Clinical Research Infrastructures Network (ECRIN) survey of ten European countries.
Trials
; 11: 104, 2010 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-21073691